Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Boston Scientific
BSX
|
+$240M |
| 2 |
eBay
EBAY
|
+$231M |
| 3 |
PXD
Pioneer Natural Resource Co.
PXD
|
+$216M |
| 4 |
Ameren
AEE
|
+$196M |
| 5 |
Kohl's
KSS
|
+$182M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$552M |
| 2 |
Micron Technology
MU
|
+$425M |
| 3 |
Visa
V
|
+$225M |
| 4 |
Marathon Petroleum
MPC
|
+$225M |
| 5 |
ESRX
Express Scripts Holding Company
ESRX
|
+$218M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 14.17% |
| 2 | Healthcare | 12.72% |
| 3 | Technology | 12.27% |
| 4 | Industrials | 11.44% |
| 5 | Consumer Discretionary | 11.23% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1276
Madrigal Pharmaceuticals
MDGL
$12B
| $10.8M | 0.01% |
92,291
+88,386
| +2,263% | +$10.9M |
|
1277
Vale
VALE
$63.8B
| $10.8M | 0.01% |
846,712
-5,202,777
| -86% | -$68.5M |
|
1278
Newmark Group
NMRK
$2.86B
| $10.8M | 0.01% |
708,445
+513,674
| +264% | +$7.95M |
|
|
ISCA
1279
DELISTED
International Speedway Corp
ISCA
| $10.7M | 0.01% |
243,685
+140,449
| +136% | +$6.11M |
|
|
BFYT
1280
DELISTED
Benefytt Technologies, Inc. Class A Common Stock
BFYT
| $10.7M | 0.01% |
369,959
+29,231
| +9% | +$820K |
|
1281
Regal Rexnord
RRX
$10.9B
| $10.7M | 0.01% |
145,570
-187,159
| -56% | -$14.1M |
|
1282
Becton Dickinson
BDX
$51.3B
| $10.6M | 0.01% |
50,363
-232,440
| -82% | -$50.9M |
|
|
CRCM
1283
DELISTED
CARE.COM, INC.
CRCM
| $10.6M | 0.01% |
653,228
+127,147
| +24% | +$2.33M |
|
1284
Neurocrine Biosciences
NBIX
$15.6B
| $10.6M | 0.01% |
127,915
-406,651
| -76% | -$34.3M |
|
1285
Bio-Techne
TECH
$11.3B
| $10.6M | 0.01% |
280,212
+5,824
| +2% | +$206K |
|
|
SUM
1286
DELISTED
Summit Materials, Inc. Class A Common Stock
SUM
| $10.6M | 0.01% |
354,684
+336,590
| +1,860% | +$10.4M |
|
1287
EPAM Systems
EPAM
$5.66B
| $10.5M | 0.01% |
+91,826
| New | +$10.5M |
|
|
CBD
1288
DELISTED
Companhia Brasileira de Distribuicao
CBD
| $10.5M | 0.01% |
520,022
+493,379
| +1,852% | +$10.7M |
|
|
CSRA
1289
DELISTED
CSRA Inc.
CSRA
| $10.5M | 0.01% |
254,541
+239,900
| +1,639% | +$8.8M |
|
|
ATSG
1290
DELISTED
Air Transport Services Group
ATSG
| $10.5M | 0.01% |
449,870
+337,224
| +299% | +$8.27M |
|
1291
PPG Industries
PPG
$25.1B
| $10.5M | 0.01% |
93,982
-394,162
| -81% | -$45.5M |
|
1292
Americold
COLD
$4.33B
| $10.4M | 0.01% |
+546,449
| New | +$9.88M |
|
1293
Enel Chile
ENIC
$6.27B
| $10.4M | 0.01% |
1,626,587
+229,426
| +16% | +$1.42M |
|
1294
AutoNation
AN
$6.38B
| $10.4M | 0.01% |
221,663
+163,429
| +281% | +$8.74M |
|
|
MDRX
1295
DELISTED
Veradigm Inc. Common Stock
MDRX
| $10.4M | 0.01% |
838,793
-719,985
| -46% | -$10.2M |
|
1296
CALL
Keurig Dr Pepper
KDP
$43.9B
| $10.4M | 0.01% |
+87,500
| New | +$9.7M |
|
|
VRE
1297
DELISTED
Veris Residential
VRE
| $10.4M | 0.01% |
619,615
+347,461
| +128% | +$6.56M |
|
|
TARO
1298
DELISTED
Taro Pharmaceutical Industries Ltd.
TARO
| $10.4M | 0.01% |
104,861
+2,787
| +3% | +$282K |
|
|
GNBC
1299
DELISTED
Green Bancorp, Inc
GNBC
| $10.3M | 0.01% |
465,071
+4,624
| +1% | +$105K |
|
|
GG
1300
DELISTED
Goldcorp Inc
GG
| $10.3M | 0.01% |
748,036
-37,860
| -5% | -$512K |
|
Similar funds
Israel Englander's Q1 2018 Portfolio in Review
As of Q1 2018, Israel Englander held 4,417 positions worth $74.9B, up 3.4% from $72.5B the previous quarter. Its ten largest holdings account for 6.3% of the portfolio.
Israel Englander deployed $3.29B of net new capital in Q1 2018, opening 664 new positions and adding to 1,466 existing holdings. Its largest new stake was Tiffany & Co.: 1,078,847 shares worth $105M.
By sector, the portfolio is most concentrated in Financials at 14% of assets, down from 14% a quarter earlier, followed by Healthcare and Technology.
On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $552M trimmed.
- Israel Englander's largest Q1 2018 buy was Tiffany & Co.: 1,078,847 shares worth $105M.
- Israel Englander added most to Boston Scientific in Q1 2018, an estimated $240M increase.
- Israel Englander's biggest Q1 2018 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $552M.
- Israel Englander fully exited Equinix in Q1 2018, selling an estimated $152M.
- Israel Englander's ten largest holdings make up 6.3% of its $74.9B portfolio in Q1 2018.
- Israel Englander opened 664 new positions and closed 833 in Q1 2018.
- Israel Englander's portfolio value rose 3.4% quarter-over-quarter to $74.9B.
Based on Millennium Management's 13F filing for Q1 2018, filed 15 May 2018.